PlainRecalls
FDA Drug Low Class III Terminated

Olanzapine, Orally Disintegrating Tablets, 10 mg, a) 30-count bottle (NDC 60505-3276-03), b) 100-count blister (NDC 60505-3276-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9

Reported: May 20, 2015 Initiated: April 7, 2015 #D-1080-2015

Product Description

Olanzapine, Orally Disintegrating Tablets, 10 mg, a) 30-count bottle (NDC 60505-3276-03), b) 100-count blister (NDC 60505-3276-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9

Reason for Recall

Subpotent drug

Details

Recalling Firm
Apotex Inc.
Units Affected
6,467 bottles/ blister cartons
Distribution
Nationwide
Location
Toronto, N/A

Frequently Asked Questions

What product was recalled?
Olanzapine, Orally Disintegrating Tablets, 10 mg, a) 30-count bottle (NDC 60505-3276-03), b) 100-count blister (NDC 60505-3276-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9. Recalled by Apotex Inc.. Units affected: 6,467 bottles/ blister cartons.
Why was this product recalled?
Subpotent drug
Which agency issued this recall?
This recall was issued by the FDA Drug on May 20, 2015. Severity: Low. Recall number: D-1080-2015.